Le Lézard
Classified in: Health
Subject: SVY

Telehealth has Become Increasingly Important in a World Where Patients Remain Hesitant to Visit Hospitals


DUBLIN, Nov. 30, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the personal health monitors industry "Telehealth has Become Increasingly Important "

Research and Markets Logo

AliveCor has received FDA clearance of new algorithms for use with their personal electrocardiogram devices which will be available via a software upgrade in 2021. AliveCor’s personal EKG devices analyze heart rate readings and help users detect atrial fibrillation, bradycardia and tachycardia from their own homes. The FDA cleared software algorithms double the number of heart rhythm disturbances that AliveCor’s devices can detect which increases the pool of patients for whom they are suitable. 

Telehealth has become increasingly important in a world where patients remain hesitant to visit hospitals and AliveCor aims to help cardiologists provide efficient remote monitoring services in cases where patients cannot meet face to face with their doctors. The company has seen a significant increase in the number of doctors recommending the devices to their patients. AliveCor reports that their Kardia devices have been used to record nearly 15 million EKG recordings since March 2020 which is an increase of 70% year over year.

To see the full article and a list of related reports on the market, visit "Telehealth has Become Increasingly Important "

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...

at 11:45
Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were...

at 11:43
- Cochlear Limited , the global leader in implantable hearing...

at 11:35
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...

at 11:33
Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award....



News published on and distributed by: